DH2i, one of the world's major providers of always-secure and always-on IT solutions, recently announced the upcoming release ...

Positive results from the global COAST 1 phase 3 study (clinical study identifier: NCT06130566) showed that amlitelimab, a fully human non-T cell depleting monoclonal antibody that targets OX40-ligand ...

Hewlett Packard Enterprise beat Wall Street estimates for third-quarter revenue on Wednesday, driven by strong demand in its server and networking segments. Demand for AI servers has surged as big ...

Amlitelimab, dosed every four weeks or every 12 weeks, demonstrated statistically significant and clinically meaningful efficacy in skin clearance and disease severity compared to placebo at Week 24, ...

🔍 List database tables 📊 Execute SQL queries (SELECT, INSERT, UPDATE, DELETE) 🔐 Multiple authentication methods (SQL, Windows, Azure AD) 🏢 LocalDB and Azure SQL support 🔌 Custom port ...